Effect of Catheter Type on Efficacy of Percutaneous Caudal Adhesolysis
NCT ID: NCT06051149
Last Updated: 2023-10-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
78 participants
INTERVENTIONAL
2024-01-31
2026-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Early or Late Foley Removal After Thoracotomy
NCT01611519
AIN Transfer for Cubital Tunnel Syndrome
NCT05242302
Fusion Imaging for EVAR With Mobile C-arm
NCT04008212
Monitoring of Bone Free Flaps With Microdialysis
NCT01879384
Accuracy of the Thoracic Epidural Catheter Insertion Confirmed by Fluoroscopic Imaging
NCT01764932
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Several causes have been introduced for FBSS including pressure on the nerve root due to disc re-herniation or retained disc fragment, epidural fibrosis, acquired stenosis, and segmental instability.
Thus, FBSS is a syndrome with diverse etiologies and noticeable heterogeneity among patients. However, about 20% to 36% of FBSS occur due to epidural fibrosis, which is a progressive disease.
The approach toward FBSS involves conservative management that consists of physical therapy and medication which aims to optimize gait and posture and can improve muscle strength and physical function. Oral pharmacological treatment of FBSS is multimodal and increasingly controversial. Treatments include antiepileptics, non-steroidal anti-inflammatory drugs, oral steroids, antidepressants, and opioids including injections, and finally surgical options as a last line therapy. Other modalities including minimally invasive procedures like epidural injections, Epidural steroid injections (ESIs) are the most commonly performed procedure in pain clinics around the world. These can be administered primarily by three approaches: transforaminal, interlaminar, or caudally, and are indicated for symptoms of radiculopathy. Also radiofrequency ablation of nerves are often used to provide sustained relief that a diagnostic block or therapeutic injection cannot provide. Successfully targeting the intended nerve is achieved, maximizing the size of the lesion. Spinal cord stimulation (SCS) is a nother treatment modality that has shown tremendous potential in the management of FBSS. Adhesions can theoretically be lysed, thereby improving baseline pain scores and drug delivery of the ESI. Lysis of adhesions typically occurs by delivering hyaluronidase with hypertonic saline into the epidural space. The use of hyaluronidase with steroid may be more effective and have longer duration of effect than either one alone. Finally, surgical revision for FBSS is associated with a high morbidity with corresponding low rates of success.
Percutaneous adhesiolysis (PA), is a minimally invasive technique, that might be useful in the treatment of chronic pain refractory to conservative treatments. The basic idea behind PA is inserting a catheter in the ventral epidural space could directly break up perineural/epidural adhesions, that act as physical barriers to the perineurally deposited drugs but also cause neural irritation predisposing to neural inflammation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Epidural Catheter
procedure Will be performed under sterile precautions utilizing fluoroscopy, RK needle.patient will be placed prone with a pillow under the abdomen.The sacral area draped from the top of the iliac crest to the bottom of the buttocks.The sacral Corns and the sacral hiatus will be palpated,is in the gluteal fold opposite the affected side will be infiltrated with lidocaine16gauge RK needle will be passed through the described entry point advanced to a point below the S3foramen to prevent S3nerve root damage.Placement will be confirmed by lateral and anteroposterior fluoroscopic views and after aspiration is negative for blood and CSF10mL of iohexol will be injected under fluoroscopy.Once the needle placement is confirmed to be in the epidural space, a lumbar epidurogram will be carried out utilizing approximately2to5 mL of contrast. then the bevel of the needle should face the ventrolateral aspect of the caudal canal.
caudal adhesolysis using RACZ Catheter
caudal adhesolysis for patients with failed back surgery syndrome using RACZ Catheter under fluroscopy
caudal adhesiolysis using NAVI Catheter
caudal adhesolysis for patients with failed back surgery syndrome using NAVI Catheter under fluroscopy
RACZ Catheter
same as procedure described above but using RACZ Catheter set
caudal adhesolysis using RACZ Catheter
caudal adhesolysis for patients with failed back surgery syndrome using RACZ Catheter under fluroscopy
NAVI catheter
same as procedure described above but using NAVI Catheter set
caudal adhesiolysis using NAVI Catheter
caudal adhesolysis for patients with failed back surgery syndrome using NAVI Catheter under fluroscopy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
caudal adhesolysis using RACZ Catheter
caudal adhesolysis for patients with failed back surgery syndrome using RACZ Catheter under fluroscopy
caudal adhesiolysis using NAVI Catheter
caudal adhesolysis for patients with failed back surgery syndrome using NAVI Catheter under fluroscopy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age ≥ 18.
* failure of conventional pharmacological management.
Exclusion Criteria
* pregnant or lactating women.
* anti-coagulant therapy.
20 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mostafa Abul-Fotouh Mohamed
principal Investigator
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AUN1615
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.